돌발성 난청 치료에서 고압산소치료의 역할
The Role of Hyperbaric Oxygen Therapy in the Treatment of Sudden Sensorineural Hearing Loss
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Sudden sensorineural hearing loss (SSNHL) is defined as acute hearing loss of >30 dB at threeconsecutive frequencies, with an abrupt onset (within 3 days). In most patients with SSNHL,an exact cause is rarely identified. Diverse etiological theories have been proposed, includingvascular disease, viral infection, autoimmune disease, inner ear hydrops, and genetic factors. Based on these hypotheses, various treatments have been tried, including corticosteroids (sys-temic and/or intratympanic), antivirals, vasoactive drugs, and hyperbaric oxygen therapy(HBOT), but the evidence remains inconclusive. The 2019 American Academy of Otolaryn-gology-Head and Neck Surgery guideline had suggested that HBOT can be provided as eitherinitial or salvage treatment when combined with steroid therapy. HBOT, a noninvasive treat-ment involving the inhalation of 100% oxygen at a pressure of >1 atmosphere absolute (ATA)is another treatment option as a method to improve oxygen supply after cochlear damage. Al-though the pressure, frequency, and total time of HBOT remain variable among differentstudies, a protocol of 2.0-2.5 ATA and 10-20 sessions in total are commonly used. The treat-ment strategies for SSNHL have been evolving, and recent attempts involved increasing theeffectiveness through various combinations of systemic steroid, intratympanic steroid, andHBOT. In this review, we will review various studies about HBOT and discuss the efficacy of HBOT in SSNHL.
Abstract
Sudden sensorineural hearing loss (SSNHL) is defined as acute hearing loss of >30 dB at threeconsecutive frequencies, with an abrupt onset (within 3 days). In most patients with SSNHL,an exact cause is rarely identified. Diverse etiological theories have been proposed, includingvascular disease, viral infection, autoimmune disease, inner ear hydrops, and genetic factors. Based on these hypotheses, various treatments have been tried, including corticosteroids (sys-temic and/or intratympanic), antivirals, vasoactive drugs, and hyperbaric oxygen therapy(HBOT), but the evidence remains inconclusive. The 2019 American Academy of Otolaryn-gology-Head and Neck Surgery guideline had suggested that HBOT can be provided as eitherinitial or salvage treatment when combined with steroid therapy. HBOT, a noninvasive treat-ment involving the inhalation of 100% oxygen at a pressure of >1 atmosphere absolute (ATA)is another treatment option as a method to improve oxygen supply after cochlear damage. Al-though the pressure, frequency, and total time of HBOT remain variable among differentstudies, a protocol of 2.0-2.5 ATA and 10-20 sessions in total are commonly used. The treat-ment strategies for SSNHL have been evolving, and recent attempts involved increasing theeffectiveness through various combinations of systemic steroid, intratympanic steroid, andHBOT. In this review, we will review various studies about HBOT and discuss the efficacy of HBOT in SSNHL.
참고문헌 (39)
- Chandrasekhar SS, "Clinical practice guideline : sudden hearing loss(update)", Otolaryngol Head Neck Surg, 161(1Suppl), pp.S1~S45 (2019)
- Stachler RJ, "Clinical practice guideline : sudden hearing loss", Otolaryngol Head Neck Surg, 146(3 Suppl), pp.S1~S35 (2012)
- Hiramatsu M, "Polymorphisms in genes involved in inflammatory pathways in patients with sudden sensorineural hearing loss", J Neurogenet, 26(3-4), pp.387~396 (2012)
- Hoffman M, "Leukocytes and coronary heart disease", Atherosclerosis, 172(1), pp.1~6 (2004)
- Hultcrantz E, "Corticosteroid treatment of idiopathic sudden sensorineural hearing loss : analysis of an RCT and material drawn from the Swedish national database", Eur Arch Otorhinolaryngol, 272(11), pp.3169~3175 (2015)
- Mathieu D, "Tenth European Consensus Conference on hyperbaric medicine : recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment", Diving Hyperb Med, 47(1), pp.24~32 (2017)
- Stobbs N, "How are we managing sudden sensorineural hearing loss in the United Kingdom? : our experience", Clin Otolaryngol, 39(6), pp.385~388 (2014)
- Olex-Zarychta D, "Hyperbaric oxygenation as adjunctive therapy in the treatment of sudden sensorineural hearing loss", Int J Mol Sci, 21(22), pp.8588~ (2020)
- Bennett MH, "Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus", Cochrane Database Syst Rev, 10, pp.CD004739~ (2012)
- Fisch U, "Management of sudden deafness", Otolaryngol Head Neck Surg, 91(1), pp.3~8 (1983)
- Kusakari J, "The effect of transient anoxia upon the cochlear potentials", Auris Nasus Larynx, 8(2), pp.55~64 (1981)
- Wang HH, "Effect of the timing of hyperbaric oxygen therapy on the prognosis of patients with idiopathic sudden sensorineural hearing loss", Biomedicines, 11(10), pp.2670~ (2023)
- Buras JA, "Endothelial-neutrophil interactions during ischemia and reperfusion injury : basic mechanisms of hyperbaric oxygen", Neurol Res, 29(2), pp.127~131 (2007)
- Mathieu D, "Handbook on hyperbaric medicine" (2006), Springer
- Lamm K, "Simultaneous determinations of oxygen partial pressure in the scala tympani, electrocochleography and blood pressure measurements in noise stress in guinea pigs", HNO, 36(9), pp.367~372 (1988)
- Undersea & Hyperbaric Medical Society, "Hyperbaric oxygen therapy indications" (2019), Best Publishing Company
- Hosokawa S, "Hyperbaric oxygen therapy as concurrent treatment with systemic steroids for idiopathic sudden sensorineural hearing loss : a comparison of three different steroid treatments", Audiol Neurootol, 23(3), pp.145~151 (2018)
- Cho I, "Comparison of two different treatment protocols using systemic and intratympanic steroids with and without hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss : a randomized controlled trial", Audiol Neurootol, 23(4), pp.199~207 (2018)
- Joshua TG, "Hyperbaric oxygen therapy for patients with sudden sensorineural hearing loss : a systematic review and meta-analysis", JAMA Otolaryngol Head Neck Surg, 148(1), pp.5~11 (2022)
- Ajduk J, "Comparison of intratympanic steroid and hyperbaric oxygen salvage therapy hearing outcomes in idiopathic sudden sensorineural hearing loss : a retrospective study", Ear Hear, 44(4), pp.894~899 (2023)
- Li H, "Intratympanic steroid therapy as a salvage treatment for sudden sensorineural hearing loss after failure of conventional therapy : a meta-analysis of randomized, controlled trials", Clin Ther, 37(1), pp.178~187 (2015)
- Lei X, "Hyperbaric oxygen therapy versus intratympanic steroid for salvage treatment of sudden sensorineural hearing loss : a systematic review and meta-analysis", Otol Neurotol, 42(8), pp.e980~e986 (2021)
- Xie S, "Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss treated with adjuvant hyperbaric oxygen therapy", Eur Arch Otorhinolaryngol, 275(1), pp.47~51 (2018)
- Hosokawa S, "Prognostic factors for idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy and intravenous steroids", J Laryngol Otol, 131(1), pp.77~82 (2017)
- Capuano L, "Hyperbaric oxygen for idiopathic sudden hearing loss : is the routine application helpful?", Acta Otolaryngol, 135(7), pp.692~697 (2015)
- Holy R, "Hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss(ISSNHL)in association with combined treatment", Undersea Hyperb Med, 38(2), pp.137~142 (2011)
- Yıldırım E, "Prognostic effect of hyperbaric oxygen therapy starting time for sudden sensorineural hearing loss", Eur Arch Otorhinolaryngol, 272(1), pp.23~28 (2015)
- Ajduk J, "Hyperbaric oxygen therapy as salvage therapy for sudden sensorineural hearing loss", J Int Adv Otol, 13(1), pp.61~64 (2017)
- Fujimura T, "Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss", Eur Arch Otorhinolaryngol, 264(8), pp.861~866 (2007)
- Liu SC, "Comparison of therapeutic results in sudden sensorineural hearing loss with", without additional hyperbaric oxygen therapy : a retrospective review of 465 audiologically controlled cases, 2011, pp.36(2), 121~128
- Tompach PC, "Cell response to hyperbaric oxygen treatment", Int J Oral Maxillofac Surg, 26(2), pp.82~86 (1997)
- Rhee TM, "Addition of hyperbaric oxygen therapy vs medical therapy alone for idiopathic sudden sensorineural hearing loss : a systematic review and meta-analysis", JAMA Otolaryngol Head Neck Surg, 144(12), pp.1153~1161 (2018)
- Kim H, "The optimized protocol of hyperbaric oxygen therapy for sudden sensorineural hearing loss", Laryngoscope, 133(2), pp.383~388 (2023)
- Heyboer M 3rd, "Hyperbaric oxygen therapy side effects-where do we stand?", J Am Coll Clin Wound Spec, 8(1-3), pp.2~3 (2018)
- Bennett MH, "Hyperbaric cataracts" (2023), StatPearls Publishing
- Satar B, "Effectiveness of hyperbaric oxygen therapy in idiopathic sudden hearing loss", J Laryngol Otol, 120(8), pp.665~669 (2006)
- Alimoglu Y, "Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases", Eur Arch Otorhinolaryngol, 268(12), pp.1735~1741 (2011)
- Liu SC, "Comparison of therapeutic results in sudden sensorineural hearing loss with", without additional hyperbaric oxygen therapy : a retrospective review of 465 audiologically controlled cases, 2011, pp.36(2), 121~128
- Ohinata Y, "Intense noise induces formation of vasoactive lipid peroxidation products in the cochlea", Brain Res, 878(1-2), pp.163~173 (2000)